Thermo Fisher Scientific Life Sciences Solutions — Goodwill increased by 20.9% to $14.91B in Q4 2025 compared to the prior quarter.
An increase suggests recent M&A activity, while a significant decrease may indicate impairment charges due to underperforming acquisitions.
Represents the intangible asset value recognized when the Life Sciences Solutions segment acquires another business for...
Common across large-cap life science firms that utilize M&A as a primary growth strategy.
tmo_segment_life_sciences_solutions_goodwill| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $10.15B | $12.34B | $14.91B |
| QoQ Change | — | +21.5% | +20.9% |
| YoY Change | — | +21.5% | +20.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.